Fresenius Medical Care sets international clinical standards in Malaysia
July 3, 2014 - Kuala Lumpur, Malaysia
Fresenius Medical Care the world's leading provider of dialysis products has set new clinical standards in Malaysia. Its clinic, The Kidney Dialysis Centre (TKDC) Taman Desa became the first private dialysis clinic in the country to achieve international accreditation since September 2013 through ACHSi.
The TKDC clinic recently celebrated its achievement of becoming the first internationally accredited private dialysis clinic in Malaysia at a ceremony when the accreditation plaque was unveiled by Dr Desmond Yen, Executive Director, ACHSi. Guests included Ministry of Health and other government officials.
Excellent renal care is of critical importance, since 60 percent of the Malaysian CKD is caused by diabetes and hypertension(1), and with more than 28,500 Malaysian patients already receiving dialysis treatment(2).
Thanks to the constant commitment of TKDC's staff, the clinic guarantees high quality operations and patient safety. With its accreditation status, TKDC will serve as a model to enhance the country's development in fulfilling safety standards and ultimately maximising patient outcomes.
Fresenius Medical Care Malaysia's Managing Director, Chee Hui Cheng stated: "It is our commitment to deliver high quality care for our patients. We have marked the first milestone in transforming the local renal landscape by attaining international accreditation. Our vision as THE RENAL COMPANY is to accredit our other Fresenius Medical Care clinics so that we take renal care in Malaysia to the next level."
ACHSi (Australian Council on Healthcare Standards International) is the leading healthcare accreditation body in Australia and has developed an international reputation providing accreditation in many countries. The principles upon which the ACHSi's programs are developed reflect the characteristics displayed by an organisation on consumer focus in care and service provision, effective leadership, continuous improvement, evidence of outcomes, and striving for best practice.(3-1)
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
(1) Vivekanand Jha, et al. (2013). Chronic kidney disease: global dimension and perspectives. The Lancet, Vol. 382, Issue 9888, Figure 2, Page 264
(2) Lim YN, Ong LM, Goh BL (2013). 20th Report of the Malaysian Dialysis and Transplant Registry 2012. Accessed June 2014; http://www.msn.org.my/fwbPagePublic.jsp?fwbPageId=pMDTReport
(3) Australian Council on Healthcare Standards International; Accessed May 2014; http://www.achs.org.au/achs-international
(4) Australian Council on Healthcare Standards International; Accessed May 2014; http://www.achs.org.au/achs-international/products-and-services/accreditation
About Fresenius Medical Care
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.5 million individuals worldwide. Through its network of 3,263 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 270,570 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
For more information about Fresenius Medical Care, visit the Company's website at www.fmc-ag.com.
Ms Eonjung Lim
Fresenius Medical Care
E Email Contact